Elimination of Purkinje Fibers by Electroporation Reduces Ventricular Fibrillation Vulnerability
Overview
Authors
Affiliations
Background The Purkinje network appears to play a pivotal role in the triggering as well as maintenance of ventricular fibrillation. Irreversible electroporation ( IRE ) using direct current has shown promise as a nonthermal ablation modality in the heart, but its ability to target and ablate the Purkinje tissue is undefined. Our aim was to investigate the potential for selective ablation of Purkinje/fascicular fibers using IRE . Methods and Results In an ex vivo Langendorff model of canine heart (n=8), direct current was delivered in a unipolar manner at various dosages from 750 to 2500 V, in 10 pulses with a 90-μs duration at a frequency of 1 Hz. The window of ventricular fibrillation vulnerability was assessed before and after delivery of electroporation energy using a shock on T-wave method. IRE consistently eradicated all Purkinje potentials at voltages between 750 and 2500 V (minimum field strength of 250-833 V/cm). The ventricular electrogram amplitude was only minimally reduced by ablation: 0.6±2.3 mV ( P=0.03). In 4 hearts after IRE delivery, ventricular fibrillation could not be reinduced. At baseline, the lower limit of vulnerability to ventricular fibrillation was 1.8±0.4 J, and the upper limit of vulnerability was 19.5±3.0 J. The window of vulnerability was 17.8±2.9 J. Delivery of electroporation energy significantly reduced the window of vulnerability to 5.7±2.9 J ( P=0.0003), with a postablation lower limit of vulnerability=7.3±2.63 J, and the upper limit of vulnerability=18.8±5.2 J. Conclusions Our study highlights that Purkinje tissue can be ablated with IRE without any evidence of underlying myocardial damage.
Mugnai G, Bolzan B, Franchi E, Capocci S, Pellegrini N, Ribichini F J Interv Card Electrophysiol. 2025; .
PMID: 39928276 DOI: 10.1007/s10840-025-02010-1.
Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias.
Yavin H, Prasad M, Gordon J, Aksu T, Huang H J Cardiovasc Dev Dis. 2025; 12(1).
PMID: 39852288 PMC: 11766314. DOI: 10.3390/jcdd12010010.
Pulsed Field Ablation: A Comprehensive Update.
Ezzeddine F, Asirvatham S, Nguyen D J Clin Med. 2024; 13(17).
PMID: 39274404 PMC: 11396515. DOI: 10.3390/jcm13175191.
Zhai Z, Ling Y, Wang Y, Shi L, Liu X Front Cardiovasc Med. 2024; 11:1426920.
PMID: 39149581 PMC: 11325456. DOI: 10.3389/fcvm.2024.1426920.
Fan A, Liu G, Wu X J Interv Card Electrophysiol. 2024; .
PMID: 39093488 DOI: 10.1007/s10840-024-01828-5.